PONTIS connects investors with carefully selected innovation companies seeking growth capital, strategic partnerships and long-term relationships.
We bring together high-quality companies and relevant investors through a curated, relationship-led approach designed to make capital access more meaningful and efficient.
Gain exposure to selected companies aligned with your investment interests.
Connect directly with founders, leadership teams and strategic decision-makers.
Discover companies with the ambition and potential to scale across international markets.
Explore companies with innovative solutions and compelling growth opportunities.
Review selected businesses seeking strategic capital and investor relationships.
Identify opportunities beyond capital through partnerships, expertise and market access.
Gain insight into emerging technologies, sectors and high-growth markets.
Meet selected companies within the PONTIS network and explore their technology, market opportunity and growth potential.
AI-enabled electromagnetic imaging designed to identify concealed threats as people move through open spaces.
iPulse Medical, Ltd. is the manufacturer of Livia, a drug-free off switch for menstrual pain. Livia is FDA, CE and Health Canada approved, and recently won the Gold for the "Women's Wellbeing" category in the prestigious Edison Awards competition. Livia has been proven in clinical testing and in real world situations to be the most effective and fastest-acting solution ever developed for menstrual pain. Unlike pain medications, Livia involves no side effects and users do not build up a tolerance to it.
STI is a private company that designs and manufactures detection and inspection systems for civil, paramilitary and policing forces
TempraMed is a medical technology company developing proprietary solutions that enhance the storage, transportation and delivery of temperature-sensitive pharmaceuticals. Its technology helps protect product integrity, improve reliability and ultimately enhance patient outcomes while saving them money.
Rise Nano Optics is advancing SPECTRAGUARD™, a patented nano-particle lens treatment engineered to selectively filter high-energy light while preserving visual clarity. The platform is designed for performance, consumer and clinical eyewear applications.
DiagnosTear is building transformative eye-based precision medicinal solutions. With four technologies the company is transforming eye care and beyond.
The Canada–Israel Capital Growth Forum brings selected innovation companies together with investors, family offices and strategic partners in a focused half-day investor experience.
Focused presentations from selected companies.
Scheduled one-to-one conversations.
High-quality connections across the capital ecosystem.
PONTIS is designed for investors looking beyond conventional deal flow and seeking access to carefully selected companies and meaningful strategic relationships.
Access differentiated growth opportunities.
Discover emerging companies with strong potential.
Connect with businesses aligned with strategic investment interests.
Explore opportunities for collaboration beyond capital.
Initiate contact to integrate with the global capital network.